First Impressions of Leading the ECMC Combination Alliance
Basic page
By Hazel Jones Combination therapies are essential in cancer, starting back in 1940s with chemotherapy combinations and expanding today to chemotherapy, radiotherapy, targeted therapy, immunotherapy and novel agents, to enable us to beat cancer sooner . Clinical validation of a wide variety of mechanisms, such as immunotherapy (recognised as a...
The Challenges, Achievements and Future Directions for the Combinations Alliance
Basic page
By Mark Saunders, Manchester ECMC The global burden of cancer continues to rise largely because of aging and population growth together with an increase in cancer-causing behaviours such as smoking, in economically developing countries. In 2008 there were nearly thirteen million new cases of cancer and almost eight million cancer...
Issue 1 - August 2013
Basic page
ECMC Network: A Year of Impact 2016/17
Basic page
Launched in 2007, the Experimental Cancer Medicines Centres (ECMC) Network is funded in partnership by Cancer Research UK and the Health Departments for England, Scotland, Wales and Northern Ireland. The ECMC Initiative supports the infrastructure needed to both deliver world-leading early phase clinical trials and to enable a network of...
Patient Satisfaction: a collaborative approach across the Experimental Cancer Medicine Centre (ECMC) Network - poster
Resource
Patient Satisfaction Survey poster
Annual Reports
Basic page
The ECMC Network publishes an Annual Report covering each financial year. Click through to the links below to read and download the reports. 2017-18: Annual Report 2015-16: Annual Report Highlights Booklet 2014-15: Annual Report Highlights Booklet 2013-14: Annual Report 2012-13: Annual Report
How to work with us
Basic page
How you can work with us: If your organisation is interested in working with the ECMC Network, please complete the Company Engagement Form , which can be found on the right. The information you provide will help us better understand how we can support you. A PDF version of the...
Quality Assurance (QA) areas of expertise
Resource
The purpose of the Quality Assurance (QA) areas of expertise document is to make those working in QA within the ECMC Network aware of others working in the same area and to give you an idea of who you can contact with certain queries. ECMC Network: QA areas of expertise...
Applications open for ECMC status in 2017-22 Quinquennium
Basic page
The ECMC Secretariat is delighted to announce the launch of applications for the upcoming Quinquennium. Existing ECMC locations are invited to apply for status for the 2017-22 period, and continue their contribution to a leading Network of early-phase clinical trials. Any location that is not currently an ECMC and wishes...
REVIEW: Cancer Research UK’s first Risk Based Monitoring (RBM) workshop
News
February 1st saw Cancer Research UK’s first Risk Based Monitoring (RBM) workshop for members of the ECMC network in collaboration with the CRUK Combinations Alliance group and the Centre for Drug Development ( CRUK CDD ). It was a full day event with participants sharing different approaches to RBM, as...